跳至主要内容
临床试验/NCT06122233
NCT06122233招募中不适用

A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease

University of Sydney8 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
8
主要终点
Change in King's Brief Interstitial Lung Disease (K-BILD) questionnaire score

研究概览

简要总结

The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is:

• Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD?

Participants in the intervention group will work through the self-management package with support from a healthcare professional via phone or Zoom. They will also enter deidentified health data into the RE-BUILD smartphone app to track their progress over time. Participants in the control group will use a reduced functionality version of the smartphone app only.

Researchers will compare both groups to see if there is any difference in health-related quality of life, symptoms, anxiety, self-efficacy and level of physical activity.

详细描述

This study compares REBUILD-SM with standard care in people with ILD. REBUILD-SM comprises a purpose-built smartphone app that allows subjects to enter and track health data over time and an integrated self-management package.

Participants will enter their respiratory diagnosis, medications and side effects, weight, lung function test results, oxygen saturation level and supplemental oxygen usage into the smartphone app. They will also complete questionnaires at specific timepoints using the app. Participants will input most of this data at the beginning of the trial and update it when it changes, for example, after obtaining a new lung function result, starting a new medication, or getting a new side effect from an existing medication. Entering data into the app is expected to take around 30 minutes at the start of the trial, and about 20 minutes at 12, 26 and 52 weeks when completing the questionnaires. Updating data is expected to take about 5-10 minutes and will only happen when there is a change, for example, once per week, although it may not be this frequent.

The app will not provide any recommendations on the health data participants enter - it is simply for recording purposes. To ensure data collection is as complete as possible, electronic reminders will be sent to participants when questionnaires are not completed at the specified timepoints and will alert the study team if the participant fails to complete the questionnaires after the reminder. This will prompt a phone call from a member of the study team to encourage the participant to complete the endpoints. App analytics will be used in the data analysis phase (after the trial is over) to understand how participants have engaged with the app.

Participants in the intervention group will be asked to log into and use the self-management website or view the content via the REBUILD app with support from the study team. The self-management content includes 13 modules and has been designed in collaboration with people with ILD to help increase their ability to self-manage their chronic disease.

During the intervention period, participants will receive four phone calls from a health professional involved in the management of people with ILD to help them set health-related goals and identify appropriate modules from the website to help achieve these goals. These four phone calls are expected to take about 15-30 minutes each.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

盲法说明

Due to the nature of the intervention, blinding will not be possible for participants and care providers (i.e. healthcare professionals making phone calls to participants). Where practicable, members of the investigative team will be blinded. Outcome assessors will also be blinded.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of fibrotic ILD
  • In possession of a smartphone/tablet and an email address
  • Able to understand written and spoken English
  • Adequate digital literacy to complete requirements of trial
  • On stable ILD treatment for 30 days prior to enrolment

排除标准

  • Not in possession of a smartphone/tablet
  • Insufficient digital literacy to complete requirements of trial
  • Unable to communicate in written/spoken English
  • Not on stable ILD treatment for 30 days prior to enrolment
  • Acute exacerbation within 30 days prior to enrolment
  • Participating in pulmonary rehab at enrolment or during 12-week intervention period
  • Unable to provide informed consent

结局指标

主要结局

Change in King's Brief Interstitial Lung Disease (K-BILD) questionnaire score

时间窗: Baseline and 12 weeks post-randomisation

Score range 0 - 100; higher score corresponding to better outcome.

次要结局

  • Change in K-BILD score(26 and 52 weeks post-randomisation)
  • Change in European Quality of Life 5-Dimensions 5-Level (EQ-5D-5L) questionnaire score(Baseline, 12, 26 and 52 weeks post-randomisation)
  • Change in General Self-Efficacy Scale score(Baseline, 12, 26, and 52 weeks post-randomisation)
  • Change in Dyspnoea-12 score(Baseline, 12, 26 and 52 weeks post-randomisation)
  • Change in Hospital Anxiety and Depression Scale score(Baseline, 12, 26 and 52 weeks post-randomisation)
  • Change in physical activity levels(Baseline, 12 and 52 weeks post-randomisation)
  • Uptake/ changes to ILD treatments(Baseline, 12, 26 and 52 weeks post-randomisation)
  • Change in mHealth App Usability questionnaire (MAUQ) score(12, 26 and 52 weeks post-randomisation)
  • Change in e-Health Literacy (eHEALS) questionnaire score(Baseline,12 and 52 weeks post-randomisation)
  • Health Care Climate questionnaire(12 weeks post-randomisation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验